Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2005
09/21/2005EP1263936B1 Altered strain of the modified vaccinia virus ankara (mva)
09/21/2005EP1212082A4 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies
09/21/2005EP1140091B1 Formulations comprising imiquimod or other immune response modifiers for treating cervical dysplasia
09/21/2005EP1137640B1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
09/21/2005EP1096934B1 Oxazolidinones to treat eye infections
09/21/2005EP1061805B1 Regulation of endogenous gene expression in cells using zinc finger proteins
09/21/2005EP0959881B1 Synthetic methods for the preparation of indolylquinones and mono- and bis-indolylquinones prepared therefrom
09/21/2005EP0925065B1 Water miscible erythromycin compositions
09/21/2005CN1671863A Central airway administration for systemic delivery of therapeutics
09/21/2005CN1671851A Flavivirus vaccine delivery system
09/21/2005CN1671844A Antigenic neisserial peptides
09/21/2005CN1671745A Polysaccharide of echinacea angustifolia
09/21/2005CN1671744A Low molecular weight oversulfated polysaccharide
09/21/2005CN1671736A Pegylated T20 polypeptide
09/21/2005CN1671735A Pegylated T1249 polypeptide
09/21/2005CN1671732A Process for purifying glycopeptide phospohonate derivatives
09/21/2005CN1671730A Oligonucleotide-containing pharmacological compositions and their use
09/21/2005CN1671727A Anti-viral 7-deaza D-nucleosides and uses thereof
09/21/2005CN1671726A 3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents
09/21/2005CN1671723A Novel difluorinated gem compounds, preparation methods thereof and applications of same
09/21/2005CN1671722A Campylobacter glycans and glycopeptides
09/21/2005CN1671715A Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors
09/21/2005CN1671710A Pyrazolo[1, 5a]pyrimidine compounds as antiviral agents
09/21/2005CN1671701A Novel aryllimidazole derivatives, preparation and therapeutic used thereof
09/21/2005CN1671696A 激酶抑制剂 Kinase inhibitors
09/21/2005CN1671694A Bisindolyl-maleimid derivatives as kinase inhibitors
09/21/2005CN1671690A Antimicrobial aza-bicyclic derivates, their compositions and uses
09/21/2005CN1671667A Quinoline derivatives and their use as mycobacterial inhibitors
09/21/2005CN1671663A Pleuromutilin
09/21/2005CN1671662A Piperidine derivative, process for producing the same, and use
09/21/2005CN1671435A Medicament dispenser
09/21/2005CN1671414A CpG formulations and related methods
09/21/2005CN1671408A Treatment of hepatitis C in the asian population with subcutaneous interferonbeta
09/21/2005CN1671385A Parenteral formulations containing a rapamycin hydroxyester
09/21/2005CN1671384A Methods of treating microbial infections in humans and animals
09/21/2005CN1671380A Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors
09/21/2005CN1670217A Process for the preparation of pseudomonic acid A antibiotic by microbiological method
09/21/2005CN1670188A Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
09/21/2005CN1670024A Acyclic nucleoside phosphonate derivatives
09/21/2005CN1669584A Process for preparing viral and bacterial vaccine for animals utilizing vegetable oil adjuvant
09/21/2005CN1669581A Medicinal composition containing dendritic cell-specific intercellular adhesion factor-3 snatch nonconformity element, cleaning supplies and uses thereof
09/21/2005CN1669580A Compound hepatitis B quench
09/21/2005CN1669572A Sow thistle extract, preparing process and application thereof
09/21/2005CN1669569A Medicine for dispelling tinea
09/21/2005CN1669567A Rough gentian soft capsule for treating hepatic diseases
09/21/2005CN1669554A Liposome vitality conazole preparation
09/21/2005CN1669553A 硫普罗宁注射液及其制备方法 Tiopronin injection and its preparation method
09/21/2005CN1219796C Application of N-end amino acid of interferon-tau polypeptide
09/21/2005CN1219780C Heterocyclic compounds binding chemotactic factor receptor
09/21/2005CN1219753C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
09/21/2005CN1219545C Polygonum capitatum extract and medicinal composition preparation thereof
09/21/2005CN1219538C Medicine for curing diarrhea and red and white dysentery
09/21/2005CN1219518C Novel medical use of 2 alpha, 23- dihydroxyl ursolic acid
09/21/2005CN1219512C Pharmaceutical compositions containing oxapenem-3-carboxylic acids
09/21/2005CN1219509C Use of rosmarinic acid and derivatives thereof as immunosuppressant or inhibitor of SHz-mediated process
09/21/2005CN1219508C Mucilage antiseptic medicine composition capable of being locally administrated and sustainably released and its preparing method
09/20/2005US6946555 Preparation of triazoles by organometallic addition to ketones and intermediates therefor
09/20/2005US6946548 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs.
09/20/2005US6946490 Medicine comprises Echinacea phytochemicals and benzalkonium chloride in a sterile water solution; for therapy
09/20/2005US6946479 for treatment of microbial infections
09/20/2005US6946478 Compounds
09/20/2005US6946469 Viricides
09/20/2005US6946466 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
09/20/2005US6946460 such as cis-4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]-N-methyl-N-(3-phenyl-2(E)-propenyl)-benzenemethanamine;
09/20/2005US6946458 N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus
09/20/2005US6946456 Administering compounds which inhibit heat shock protein 90 proteins; methods block Rb negative or deficient cells in the G2/M phase of the cell cycle and rapidly causes their destruction
09/20/2005US6946253 Azodicarbonamide ejects zinc bound to protein; solid phase synthesis; nuclear magnetic resonance
09/20/2005US6946244 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator
09/20/2005US6946136 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (HPIV-2) and vaccines based on such virus
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/20/2005CA2231535C Imidazole derivatives having affinity for alpha2 receptors activity
09/20/2005CA2189882C Papillomavirus vaccines
09/20/2005CA2125978C Improvements in chemical compounds
09/20/2005CA2119757C New fluoro quinoline carboxylic-3 acid derivatives and their preparation
09/15/2005WO2005085446A1 Method of selecting bird resistant to rna virus
09/15/2005WO2005085445A1 Recombinant varicella-zoster virus
09/15/2005WO2005085418A1 Novel lactic acid bacterium
09/15/2005WO2005085274A1 Toll-like receptor 2 (tlr-2) haplotypes predict outcome of patients
09/15/2005WO2005085264A1 Sulfated oligosaccharide derivatives
09/15/2005WO2005085258A1 3-pyridinium methylcephem compound
09/15/2005WO2005085212A1 Substituted pyrimidine derivative
09/15/2005WO2005085210A1 Nitriles and medicinal compositions containing the same as the active ingredient
09/15/2005WO2005085209A1 Basic amine compound and use thereof
09/15/2005WO2005084786A1 Water containing oxygen nano bubbles and method for production thereof
09/15/2005WO2005084704A1 Digestive bypass composition for arthropod and uses thereof
09/15/2005WO2005084694A1 Influenza virus-infection inhibitor
09/15/2005WO2005084657A1 Compositions and methods for preventing or treating an inflammatory response
09/15/2005WO2005002511A3 Recombinant antibodies and compositions and methods for making and using the same
09/15/2005WO2002048388A3 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell
09/15/2005US20050203295 NO donor has a nitroso group attached to a tertiary carbon; vascular relaxants, nonsteroidal anti-inflammatory drug; water soluble; potentiated by adding glutathione, use low dosage
09/15/2005US20050203181 Acyloxymethyl esters of C6-14 alkane-dicarboxylic acids, higher absorbtion of esters; does not induce bacterial resistance
09/15/2005US20050203155 Imidazole compounds and human cellular proteins casein kinase I alpha, delta and epsilon as targets for medical intervention against Hepatitis C Virus infections
09/15/2005US20050203144 Use against multi-drug resistant staphylococci, streptococci, enterococci, Bacteroides, Clostridia, Mycobacterium tuberculosis; e.g. N-[5(S)-3-[3,5-Difluoro-4-[(1alpha,5alpha,6alpha )-6-[(2-(1,3-dihydroxy)propyloxy)iminomethyl]-3-azabicyclo[3.1.0]hexan-3-yl]phenyl]-2-oxooxazolidin-5-ylmethyl]acetamide
09/15/2005US20050203114 Pyrimidine-indole derivatives; cancer, autoimmunological, metabolic, inflammatory, infection (bacterial, viral, yeast, fungal, etc.), diseases of the central nervous system, degenerative neural disease, allergy/asthma, dermatology, angiogenesis, neovascularization, vasculogenesis, and cardiovascular
09/15/2005US20050203109 Novel Compounds
09/15/2005US20050203106 Viricide against herpes virus; 3-(2-Fluoropyridin-4-yl)-2-phenyl-7-pyrrolidin-1-ylpyrazolo[1,5-a]pyrimidine; chemical synthesis
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/15/2005US20050203084 Protease inhibitors
09/15/2005US20050203029 Agents for treating <I>flaviviridae</I>infections
09/15/2005US20050203006 Novel lipopeptides as antibacterial agents
1 ... 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 ... 1798